Real world comparison of commercial CAR T-cell constructs for the treatment of LBCL
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Megan Melody, Alan Kerr, Megan Herr, Adit Dharia, Nicole Altomare, Natalie Grover, Colin Thomas, Omar Elghawy, Yun Kyoung Tiger, Alexandra Noveihed, Ari Pelcovits, Thomas Ollila, Matthew Cortese, James Davis, Adam Kidwell, Tamara Moyo, Lindsey Fitzgerald, Jonathon Cohen, Nikesh Shah, David Swoboda, Vaishalee Kenkre, Geoffrey Shouse, Daniel Antonio, Deborah Stephens, Nirav Shah, Jonathan Moreira, Shuo Ma, Jane Winter, Leo Gordon, Narendranath Epperla, Reem Karmali, Brian Hess
Institutions: Tampa General Hospital, Roswell Park Comprehensive Cancer Center, University of South Florida, Northwestern University, University of North Carolina at Chapel Hill, Abramson Cancer Center, University of Pennsylvania, Rutgers Cancer Institute, Brown University, Medical University of South Carolina, MUSC Hollings Cancer Center, Medical College of Wisconsin, Medical College of Wisconsin Cancer Center, Levine Cancer Institute, University of Utah, Huntsman Cancer Institute, Emory University, Winship Cancer Institute, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, City Of Hope National Medical Center, City of Hope, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417019377
Cites:
Cited by:
Related to: